Stepping Into Lifestyle Changes (SILC)

August 20, 2025 updated by: Monica L Baskin, University of Alabama at Birmingham

Community-Based Strategies to Reduce Cardiometabolic Disease in the Deep South

The purpose of this study is to promote healthy weight loss among African American women, age 30 or older, who are pre-diabetic and/or have high blood pressure and who live, work, or worship in select rural communities throughout Alabama and Mississippi. The goal of the study is to help reduce the burden of obesity, diabetes, and high blood pressure for these women and to collect information on the reach, effectiveness, adoption, implementation, maintenance, and cost effectiveness of our two evidence-base weight loss programs.

Study Overview

Detailed Description

This study leverages two evidence-based interventions (EBIs) that have been culturally-adapted for the target population and have previously achieved clinically-relevant weight loss and other clinical outcomes (educational group weight loss intervention) along with improvements in diet and physical activity (home gardening intervention). Combining these EBIs addresses multiple domains (behavioral, personal environment, sociocultural) and levels (individual, interpersonal, community) of influence on risk factors for obesity and other cardiometabolic diseases prevalent in the Deep South. These interventions, delivered by local lay staff and non-academic partners, have a high potential for sustainability; however, there is a need to further evaluate the external validity and implementation-related barriers and facilitators to maximize reach, adoption and implementation. The investigators will employ a pragmatic, multilevel, cluster-randomized, type 1 hybrid effectiveness-implementation trial. A total of 264 Black women (age ≥ 30 years) with overweight or obesity and pre-diabetic or hypertensive from 12 rural counties (6 Alabama, 6 Mississippi) will receive either the combined educational group weight loss intervention plus a home gardening intervention or the educational group weight loss classes alone. The specific aims are to compare interventions on: (1) primary outcomes related to implementation effectiveness (reach, adoption, maintenance of health behaviors), (2) secondary outcomes on clinical effectiveness, and (3) cost effectiveness. Findings will inform discussions with coalition partners to achieve our long-term goal of widely disseminating and sustaining multi-level interventions to reduce the multiple chronic disease burden and health disparities in the Deep South.

Study Type

Interventional

Enrollment (Actual)

273

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35294
        • The University of Alabama at Birmingham
    • Mississippi
      • Jackson, Mississippi, United States, 39216
        • The University of Mississippi Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • self-identifies as Black and/or African American
  • ≥ 30 years old
  • a measured BMI >25 kg/m2 and at least one other cardiometabolic risk factor (physician diagnosis of pre-diabetes and/or hypertension within past 2 years)
  • lives, works, or worships in one of the 12 intervention communities and expresses no intentions to move outside of that community in the 18 months following enrollment
  • a willingness to participate in the study for the 18-months duration.

Exclusion Criteria:

  • being or planning to become pregnant during the 18-month study duration
  • a baseline blood pressure and/or glucose that is outside of the normal range and a medical provider does not provide clearance to participate
  • medical contraindications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Educational Group Weight Loss Classes
Participants will participate in a 12-month weight loss program, taught by lay health educators, and designed to promote and encourage healthy weight loss, dietary changes, and increased physical activity. Participants will attend 90-minute sessions weekly for 6 months, bi-weekly for 3 months, and monthly for 3 months.
Participants will be provided with educational materials on weight loss, and have opportunities to increase their exercise and make changes to their diet.
Experimental: Educational Group Weight Loss Classes PLUS Home Gardening Intervention
Participants will receive the educational group weight loss classes PLUS a home gardening intervention. The gardening intervention will be led by local Master Gardeners (MGs) who will help guide participants in setting-up and maintaining their garden.
Participants will be provided with educational materials on weight loss, and have opportunities to increase their exercise and make changes to their diet.
Participants will receive tools to establish their own home garden, increasing their access to fresh fruits and vegetables.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight
Time Frame: 0, 6, and 12 months
Changes in Weight, measured in pounds
0, 6, and 12 months
BMI
Time Frame: 0, 6, and 12 months
Changes in BMI, calculated as a person's weight in kilograms divided by the square of height in meters
0, 6, and 12 months
Waist Circumference
Time Frame: 0, 6, and 12 months
Changes in waist circumference, measured in centimeters
0, 6, and 12 months
Dietary Intake
Time Frame: 0, 6, and 12 months
Changes in diet, measured using a questionnaire
0, 6, and 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diastolic and Systolic Blood Pressure
Time Frame: 0, 6, and 12 months
Changes in values over time, using a calibrated automatic sphygmomanometer and following NHLBI protocols
0, 6, and 12 months
Fasting Glucose
Time Frame: 0, 6, and 12 months
Changes in glucose readings, collected by finger-stick
0, 6, and 12 months
Cholesterol Levels
Time Frame: 0, 6, and 12 months
Changes in LDL and HDL values/ratio, collected by finger-stick
0, 6, and 12 months
Physical Activity
Time Frame: 0, 6, and 12 months

Changes in physical activity, measured by the International Physical Activity Questionnaire (IPAQ).

For the IPAQ survey, participants will be asked to indicate if they have completed low (sitting or walking) levels of activity, moderate levels of activity, and/or high levels of activity in the last 7 days.They will also be asked to provide the number of days they do each activity and the time, in minutes, they spend doing the activity.

0, 6, and 12 months
Physical Activity
Time Frame: 0, 6, and 12 months

Changes in physical activity, measured by the Stanford Leisure Time Activity Categorical Item (L-cat).

The L-Cat is categorical and responses range from 1-6 with 1 indicating little to no physical activity, and 6 indicating vigorous activity for 5 or more days a week.

0, 6, and 12 months
Perceived Quality of Life
Time Frame: 0, 6, and 12 months
Changes in Quality of Life as measured by the EuroQol-5 Dimension survey (EQ-5D-5L). Condition states range from 1-5 with 1 meaning the participant has no problems or symptoms and 5 meaning they have are unable to perform the activity or are extremely impacted by the condition. Self reported health is measured on a 1 to 100 scale with 1 being the worst possible health and 100 being the best possible health.
0, 6, and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Monica Baskin, PhD, University of Alabama at Birmingham

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 27, 2023

Primary Completion (Actual)

June 30, 2025

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

November 2, 2022

First Submitted That Met QC Criteria

November 21, 2022

First Posted (Actual)

November 22, 2022

Study Record Updates

Last Update Posted (Estimated)

August 27, 2025

Last Update Submitted That Met QC Criteria

August 20, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on Educational Group Weight Loss Classes

Subscribe